GENSCRIPT BIO: ANNUAL REPORT 2023
GENSCRIPT BIO: OVERSEAS REGULATORY ANNOUNCEMENT: UNAUDITED FINANCIAL RESULTS FOR THE FOURTH QUARTER AND THE YEAR ENDED 31 DECEMBER 2023 OF A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
GENSCRIPT BIO: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
GENSCRIPT BIO: DATE OF BOARD MEETING
GENSCRIPT BIO: OVERSEAS REGULATORY ANNOUNCEMENT - UNAUDITED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED 30 SEPTEMBER 2023 BY A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
GENSCRIPT BIO: INTERIM REPORT 2023
GENSCRIPT BIO: ANNOUNCEMENT OF UNAUDITED CONSOLIDATED INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2023
GENSCRIPT BIO: INSIDE INFORMATION AND OVERSEAS REGULATORY ANNOUNCEMENT: (1) UNAUDITED FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED 30 JUNE 2023 BY A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION AND (2) ACHIEVING MAJOR MILESTONE IN THE COLLABORATION WIT
GENSCRIPT BIO: DATE OF BOARD MEETING
GENSCRIPT BIO: OVERSEAS REGULATORY ANNOUNCEMENT - UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED 31 MARCH 2023 BY A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
GENSCRIPT BIO: ANNUAL REPORT 2022
GENSCRIPT BIO: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
GENSCRIPT BIO: OVERSEAS REGULATORY ANNOUNCEMENT: RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022 OF A LISTED SUBSIDIARY LEGEND BIOTECH CORPORATION
GENSCRIPT BIO: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
GENSCRIPT BIO: DATE OF BOARD MEETING
GENSCRIPT BIO: SUPPLEMENTAL ANNOUNCEMENT TO THE INSIDE INFORMATION AND OVERSEAS REGULATORY ANNOUNCEMENT: UPDATE ON RESTATEMENT OF FINANCIAL STATEMENTS OF LEGEND BIOTECH
Genscript Biotech Corporation: OVERSEAS REGULATORY ANNOUNCEMENT: FINANCIAL RESULTS FOR THE SECOND QUARTER AND HALF YEAR ENDED 30 JUNE 2022 OF A LISTED SUBSIDIARY LEGEND BIOTECH CORPORATION
Genscript Biotech Corporation: INSIDE INFORMATION AND OVERSEAS REGULATORY ANNOUNCEMENT: UPDATE ON RESTATEMENT OF FINANCIAL STATEMENTS OF LEGEND BIOTECH
Genscript Biotech Corporation: INTERIM REPORT 2022
Genscript Biotech Corporation: ANNOUNCEMENT OF UNAUDITED CONSOLIDATED INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2022
No Data